The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA). The approval ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Researchers at The Institute of Cancer Research, London, have uncovered a hidden weakness in some breast cancer tumours that could lead to smarter treatment decisions. One of the body’s natural ...

"Search" is our twice-yearly newsletter to supporters. In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

In April 2019, Claire Shepherd, now 34, began feeling unwell and constantly fatigued. Having initially put her symptoms down to her hectic lifestyle, she was shocked to be diagnosed with acute myeloid ...

New research into how cancer develops has uncovered more detail about the importance of the centromere, a region of human DNA that has a critical role in effective cell division. Researchers have ...

The Magnetic Resonance group develops and tests new probes, instrumentation and techniques to better plan and assess cancer treatment. Our research is principally focused on the further development ...